“With such an exciting lineup of new products to complement the existing portfolio, we plan to accelerate our U.S. investment in the second half.”

In context

“Emmanuel Babeau: As a related aside, I will note that while scanner data typically provide a good directional indication of volume trend, it does not always fully capture the effective consumer price. We plan further extension in the coming months, including the introduction of 1.5 milligram and eight milligram dry formats in Q3. Together, these launches will broaden our offering with an expanded range of strengths and taste profiles, enabling us to better address the spectrum of legal-age consumer preferences and further strengthen our competitive positioning across segments. With such an exciting lineup of new products to complement the existing portfolio, we plan to accelerate our U.S. investment in the second half. This includes a comprehensive commercial program across marketing, distribution, and in-store execution with a rollout of our major new brand campaign, When it Clicks, starting this month to support brand engagement and consumer relevance.”